Polymorphisms in Endothelin System Genes, Arsenic Levels and Obesity Risk

Background/Objectives Obesity has been linked to morbidity and mortality through increased risk for many chronic diseases. Endothelin (EDN) system has been related to endothelial function but it can be involved in lipid metabolism regulation: Receptor type A (EDNRA) activates lipolysis in adipocytes, the two endothelin receptors mediate arsenic-stimulated adipocyte dysfunction, and endothelin system can regulate adiposity by modulating adiponectin activity in different situations and, therefore, influence obesity development. The aim of the present study was to analyze if single nucleotide polymorphisms (SNPs) in the EDN system could be associated with human obesity. Subjects/Methods We analyzed two samples of general-population-based studies from two different regions of Spain: the VALCAR Study, 468 subjects from the area of Valencia, and the Hortega Study, 1502 subjects from the area of Valladolid. Eighteen SNPs throughout five genes were analyzed using SNPlex. Results We found associations for two polymorphisms of the EDNRB gene which codifies for EDN receptor type B. Genotypes AG and AA of the rs5351 were associated with a lower risk for obesity in the VALCAR sample (p=0.048, OR=0.63) and in the Hortega sample (p=0.001, OR=0.62). Moreover, in the rs3759475 polymorphism, genotypes CT and TT were also associated with lower risk for obesity in the Hortega sample (p=0.0037, OR=0.66) and in the VALCAR sample we found the same tendency (p=0.12, OR=0.70). Furthermore, upon studying the pooled population, we found a stronger association with obesity (p=0.0001, OR=0.61 and p=0.0008, OR=0.66 for rs5351 and rs3759475, respectively). Regarding plasma arsenic levels, we have found a positive association for the two SNPs studied with obesity risk in individuals with higher arsenic levels in plasma: rs5351 (p=0.0054, OR=0.51) and rs3759475 (p=0.009, OR=0.53) Conclusions Our results support the hypothesis that polymorphisms of the EDNRB gene may influence the susceptibility to obesity and can interact with plasma arsenic levels.

[1]  N. Di Daniele,et al.  The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications. , 2014, Life sciences.

[2]  C. Bouchard,et al.  Replication of 6 Obesity Genes in a Meta-Analysis of Genome-Wide Association Studies from Diverse Ancestries , 2014, PloS one.

[3]  R. Cooper,et al.  Impact of obesity-related genes in Spanish population , 2013, BMC Genetics.

[4]  H. Knutsen,et al.  Essential and toxic element concentrations in blood and urine and their associations with diet: results from a Norwegian population study including high-consumers of seafood and game. , 2013, The Science of the total environment.

[5]  F. Ambrosio,et al.  Arsenic-stimulated lipolysis and adipose remodeling is mediated by G-protein-coupled receptors. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  P. Trainor,et al.  The developmental etiology and pathogenesis of Hirschsprung disease. , 2013, Translational research : the journal of laboratory and clinical medicine.

[7]  D. Werring,et al.  Genetic risk factors for intracranial aneurysms , 2013, Neurology.

[8]  N. Bartolomeo,et al.  Elevated endothelin-1 (ET-1) levels may contribute to hypoadiponectinemia in childhood obesity. , 2013, The Journal of clinical endocrinology and metabolism.

[9]  C. Crainiceanu,et al.  Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. , 2012, American journal of epidemiology.

[10]  Liang-Yi Wu,et al.  Endothelin-1 stimulates suppressor of cytokine signaling-3 gene expression in adipocytes. , 2012, General and comparative endocrinology.

[11]  E. Guallar,et al.  Arsenic Exposure and Cardiovascular Disease:An Updated Systematic Review , 2012, Current Atherosclerosis Reports.

[12]  Joaquín Dopazo,et al.  Select Your SNPs (SYSNPs): a web tool for automatic and massive selection of SNPs , 2012, Int. J. Data Min. Bioinform..

[13]  M. Longnecker,et al.  Evaluation of the Association between Arsenic and Diabetes: A National Toxicology Program Workshop Review , 2012, Environmental health perspectives.

[14]  M. Alemany.  Regulation of adipose tissue energy availability through blood flow control in the metabolic syndrome. , 2012, Free radical biology & medicine.

[15]  Yusuke Nakamura,et al.  Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA. , 2012, Human molecular genetics.

[16]  M. Tesauro,et al.  Human obesity and endothelium‐dependent responsiveness , 2012, British journal of pharmacology.

[17]  N. Stachenfeld,et al.  Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome , 2011, The Journal of physiology.

[18]  T. Gustafsson,et al.  Endothelin-1 Reduces Glucose Uptake in Human Skeletal Muscle In Vivo and In Vitro , 2011, Diabetes.

[19]  David Lagares,et al.  Role of endothelin in the cardiovascular system. , 2011, Pharmacological research.

[20]  Mengling Liu,et al.  Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study , 2011, BMJ : British Medical Journal.

[21]  S. Tangye,et al.  Inflammatory Mechanisms in Obesity , 2013 .

[22]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[23]  Jon Genuneit,et al.  Unifying Candidate Gene and GWAS Approaches in Asthma , 2010, PloS one.

[24]  D. Webb,et al.  Endothelium-derived endothelin-1 , 2010, Pflügers Archiv - European Journal of Physiology.

[25]  R. Loos,et al.  Recent progress in the genetics of common obesity. , 2009, British journal of clinical pharmacology.

[26]  M. Yanagisawa,et al.  Endothelin: 20 years from discovery to therapy. , 2008, Canadian journal of physiology and pharmacology.

[27]  M. Barton.  Reversal of proteinuric renal disease and the emerging role of endothelin , 2008, Nature Clinical Practice Nephrology.

[28]  Thomas J. Hudson,et al.  Differential Allelic Expression in the Human Genome: A Robust Approach To Identify Genetic and Epigenetic Cis-Acting Mechanisms Regulating Gene Expression , 2008, PLoS genetics.

[29]  T. Olsson,et al.  Vascular Peptide Endothelin-1 Links Fat Accumulation With Alterations of Visceral Adipocyte Lipolysis , 2008, Diabetes.

[30]  C. Tei,et al.  Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension , 2007, Journal of Human Hypertension.

[31]  C. Juan,et al.  Endothelin-1 regulates adiponectin gene expression and secretion in 3T3-L1 adipocytes via distinct signaling pathways. , 2007, Endocrinology.

[32]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[33]  S. Malnick,et al.  The medical complications of obesity. , 2006, QJM : monthly journal of the Association of Physicians.

[34]  A. Leite-Moreira,et al.  Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. , 2006, Pharmacology & therapeutics.

[35]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[36]  C. Juan,et al.  Effect of Endothelin‐1 on Lipolysis in Rat Adipocytes , 2006, Obesity.

[37]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[38]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[39]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[40]  L. Ho,et al.  Endothelin-1 increases glucose transporter glut1 mRNA accumulation in 3T3-L1 adipocytes by a mitogen-activated protein kinase-dependent pathway. , 2001, Cellular signalling.

[41]  J. Olefsky,et al.  The Acute and Chronic Stimulatory Effects of Endothelin-1 on Glucose Transport Are Mediated by Distinct Pathways in 3T3-L1 Adipocytes* *This work was supported by NIH Grant DK-33651. , 2000, Endocrinology.

[42]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[43]  D. Strachan,et al.  Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture , 2013 .

[44]  A. Awan,et al.  Novel mutations of endothelin-B receptor gene in Pakistani patients with Waardenburg syndrome , 2011, Molecular Biology Reports.

[45]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[46]  S. Borrego,et al.  New roles of EDNRB and EDN3 in the pathogenesis of Hirschsprung disease , 2010, Genetics in Medicine.

[47]  J. Laurencikiene,et al.  Endothelin-1 stimulates human adipocyte lipolysis through the ETA receptor , 2009, International Journal of Obesity.

[48]  David S. Paul,et al.  Environmental arsenic as a disruptor of insulin signaling. , 2008, Metal ions in biology and medicine : proceedings of the ... International Symposium on Metal Ions in Biology and Medicine held ... = Les ions metalliques en biologie et en medecine : ... Symposium international sur les ions metalliques ....